FDA.reportPublic FDA data

Depakote 125 MG Delayed Release Oral Tablet

RxCUI
1099626
RxNorm name
Depakote 125 MG Delayed Release Oral Tablet
Display name
Depakote 125 MG Delayed Release Oral Tablet
Full name
Depakote 125 MG Delayed Release Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:46

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DepakoteDIVALPROEX SODIUMAbbVie Inc.08a65cf4-7749-4ceb-6895-8f4805e2b01f2026-03-31Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1099626

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
08a65cf4-7749-4ceb-6895-8f4805e2b01fDepakote 125 MG Delayed Release Oral Tablet [PSN] · divalproex sodium 125 MG Delayed Release Oral Tablet [Depakote] [SBD] · Depakote 125 MG Delayed Release Oral Tablet [SY]31621These highlights do not include all the information needed to use Depakote safely and effectively. See full prescribing information for Depakote. Depakote (divalproex sodium) delayed-release tablets, for oral use Initial U.S. Approval: 198320260331